Skip to main content
Premium Trial:

Request an Annual Quote

Notre Dame Team Wins $2.9M NIH Grant for ExRNA Analysis Platform

NEW YORK — A University of Notre Dame research team has won a $2.9 million grant from the National Institutes of Health to develop an extracellular RNA isolation and analysis platform for diagnostic applications, the university announced this week.

According to the project's lead investigator Hsueh-Chia Chang, the platform uses low-resistance membranes with asymmetric nanopores to isolate exosomes from blood at yields greater than existing products based on size exclusion, filtration, or ultra-centrifugation. A surface acoustic wave-based microfluidic device is then used to separate the exosomes from their extracellular exRNA cargo, such as microRNAs, for analysis as biomarkers.

"Current technology has allowed for the identification of exRNA, but slowly, and the results are typically inefficient and lack the quality needed to determine a diagnosis," Chang said in a statement. "Our proposed diagnostic platform will separate the nanoparticle carriers, release their exRNA cargo, and then identify the disease biomarkers, all by integrating an array of technologies invented by our research team here at Notre Dame."

Chang will also collaborate with Notre Dame's Crislyn D'Souza-Schorey to investigate exRNAs as cancer biomarkers.

The Scan

Billion-Dollar Diversity Initiative

The Howard Hughes Medical Institute is now accepting applications for its new $1.5 billion initiative to boost the diversity of the scientific workforce.

Biotech Co-Founder Arrested

A co-founder of a Los Angeles-based biotech company has been arrested in connection with a murder-for-hire scheme, according to Endpoint News.

Return of the Tasmanian Tiger

The Washington Post reports that a team in Australia is working to bring the thylacine back from extinction.

Nature Papers on Genome of Individual From Pompeii, CircRNA Study Best Practices, More

In Nature this week: first sequenced genome of a person from Pompeii, best practice guidelines for circRNA studies, and more.